Empagliflozin

12 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Empagliflozin
Treatment and conditionWhere it standsTrials
Empagliflozin for cardiomyopathy, hypertrophicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Empagliflozin for heart defects, congenitalPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Empagliflozin for heart failurePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)13
Empagliflozin for heart failure, diastolicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for ketosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for kidney failure, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Empagliflozin for non-alcoholic fatty liver diseaseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for ventricular dysfunction, rightPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1